相关实验视频

Updated: Jul 18, 2025

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

对于中枢神经系统恶性瘤的瘤病毒疗法的光动力学增强

Kazuhide Shimizu¹, Andranik Kahramanian², Muzammil Arif Din Abdul Jabbar³

¹Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA; Department of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.

|August 24, 2023

概括

瘤病毒G47Δ-KR与光动力学治疗相结合,对脑癌产生强大的抗瘤作用. 这种光动力学结性病毒治疗方法需要进一步研究临床转化.

科学领域:

瘤治疗性病毒疗法
光动力学疗法是一种光动力学疗法.
癌症研究癌症研究

背景情况:

瘤病毒 (OV) 具有治疗耐火性癌症的潜力,包括中枢神经系统恶性瘤.
将OV与其他疗法结合起来可以通过改善瘤细胞杀死和修改瘤微环境 (TME) 来提高疗效.
光动力疗法 (PDT) 诱导癌细胞死亡,并启动TME与二次治疗的协同效应.

研究的目的:

开发和评估一种新的光动力学瘤病毒 (PD-OV) 疗法.
评估G47Δ-KR的疗效,一种表达KillerRed的瘤性简单疹病毒,与光激活相结合.
研究PD-OV治疗神经瘤恶性瘤的治疗潜力.

主要方法:

工程设计的G47Δ-KR色病毒表达KillerRed (KR) 光敏感剂.
在体外评估KR表达,反应性氧物种 (ROS) 生产以及在LED照明下质母细胞瘤 (GBM) 和恶性脑膜瘤 (MM) 细胞中的细胞毒性.
在GBM和MM异种移植模型中,使用内注射G47Δ-KR和激光照射进行PD-OV治疗疗效的体内评估.
瘤组织的RNA测序分析,以评估治疗后免疫细胞透情况.

主要成果:

在LED激活时,G47Δ-KR表达和随后的ROS生成导致了在体外增强的癌细胞死亡.
在体内,PD-OV疗法表现出显著的抗瘤作用,超过G47Δ-KR或单独的光疗.
在PD-OV治疗后,RNA测序揭示了TME内的免疫细胞透率增加.

结论:

G47Δ-KR使神经瘤恶性瘤的光动力学瘤病毒 (PD-OV) 有效治疗成为可能.
组合疗法显示了增强抗瘤反应和调节瘤免疫微环境的前景.
需要进一步的研究来推进PD-OV战略的临床应用.

关键词:

质母细胞瘤 (glioblastoma) 是一个杀手红色杀手红色恶性脑膜瘤是一种恶性脑膜瘤.瘤性简单疹病毒光动力学疗法是一种光动力学疗法.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...